FDA Approved: LATISSE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for LATISSE (bimatoprost) to expand its labeling related to eyelash growth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotrichosis of the Eyelashes

Drugs mentioned

• LATISSE (BIMATOPROST)

Snippet

SUPPL AP for LATISSE (BIMATOPROST)